ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript
ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q2 2025 Earnings Call Transcript December 10, 2024 ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $-0.09 EPS, expectations were $-0.07. Operator: Good morning, ladies and gentlemen, …